These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
114 related items for PubMed ID: 10389906
21. Transforming growth factor-beta type II receptors and smad proteins in follicular thyroid tumors. West J, Munoz-Antonia T, Johnson JG, Klotch D, Muro-Cacho CA. Laryngoscope; 2000 Aug; 110(8):1323-7. PubMed ID: 10942134 [Abstract] [Full Text] [Related]
22. Transforming growth factor-beta isoform and receptor expression in chondrosarcoma of bone. Masi L, Malentacchi C, Campanacci D, Franchi A. Virchows Arch; 2002 May; 440(5):491-7. PubMed ID: 12021923 [Abstract] [Full Text] [Related]
23. The expression of TGF-beta receptors in human atherosclerosis: evidence for acquired resistance to apoptosis due to receptor imbalance. McCaffrey TA, Du B, Fu C, Bray PJ, Sanborn TA, Deutsch E, Tarazona N, Shaknovitch A, Newman G, Patterson C, Bush HL. J Mol Cell Cardiol; 1999 Sep; 31(9):1627-42. PubMed ID: 10471347 [Abstract] [Full Text] [Related]
24. Immunohistochemical detection of X-linked inhibitor of apoptosis in head and neck squamous cell carcinoma. Nagi C, Xiao GQ, Li G, Genden E, Burstein DE. Ann Diagn Pathol; 2007 Dec; 11(6):402-6. PubMed ID: 18022123 [Abstract] [Full Text] [Related]
25. Defective expression of transforming growth factor beta type II receptor (TGFBR2) in the large cell variant of non-small cell lung carcinoma. Xu JB, Bao Y, Liu X, Liu Y, Huang S, Wang JC. Lung Cancer; 2007 Oct; 58(1):36-43. PubMed ID: 17566598 [Abstract] [Full Text] [Related]
26. The expression of matrix metalloproteinases-9, transforming growth factor-beta1 and transforming growth factor-beta receptor I in human atherosclerotic plaque and their relationship with plaque stability. Jiang X, Zeng HS, Guo Y, Zhou ZB, Tang BS, Li FK. Chin Med J (Engl); 2004 Dec; 117(12):1825-9. PubMed ID: 15603712 [Abstract] [Full Text] [Related]
27. Immunohistochemical localization of TGF-beta type II receptor and TGF-beta3 during palatogenesis in vivo and in vitro. Cui XM, Warburton D, Zhao J, Crowe DL, Shuler CF. Int J Dev Biol; 1998 Sep; 42(6):817-20. PubMed ID: 9727838 [Abstract] [Full Text] [Related]
28. Expression of vascular endothelial growth factor and microvessel density in head and neck tumorigenesis. Tae K, El-Naggar AK, Yoo E, Feng L, Lee JJ, Hong WK, Hittelman WN, Shin DM. Clin Cancer Res; 2000 Jul; 6(7):2821-8. PubMed ID: 10914730 [Abstract] [Full Text] [Related]
29. The expression levels and the differential expression of transforming growth factor-beta receptors in dermatofibroma and dermatofibrosarcoma protuberans. Kubo M, Ihn H, Yamane K, Tamaki K. Br J Dermatol; 2006 May; 154(5):919-25. PubMed ID: 16634896 [Abstract] [Full Text] [Related]
31. FK506, transforming growth factor-beta1 and mesangial matrix synthesis: parallels and differences compared with cyclosporine A. Waiser J, Dell K, Kreutzkamp J, Böhler T, Budde K, Peters H, Neumayer HH. Cytokine; 2006 Jan 21; 33(2):59-65. PubMed ID: 16458528 [Abstract] [Full Text] [Related]
32. Expression of TGFbeta type-II receptor in association with markers of proliferation and apoptosis in premalignant lung lesions. Muñoz-Antonia T, Muro-Cacho C, Sharma S, Cantor A, Bepler G. Cancer; 2007 Oct 01; 110(7):1527-31. PubMed ID: 17676583 [Abstract] [Full Text] [Related]
34. Rapid closure of midgestational excisional wounds in a fetal mouse model is associated with altered transforming growth factor-beta isoform and receptor expression. Goldberg SR, McKinstry RP, Sykes V, Lanning DA. J Pediatr Surg; 2007 Jun 01; 42(6):966-71; discussion 971-3. PubMed ID: 17560204 [Abstract] [Full Text] [Related]
35. Deletion of one adenine base within the polyadenine tract of transforming growth factor-beta receptor type II in human MDA-MB-231 breast cancer cell line. Park B, Jang JS, Park K. Int J Oncol; 2000 Sep 01; 17(3):473-8. PubMed ID: 10938386 [Abstract] [Full Text] [Related]
36. Expression of CD34, alpha-smooth muscle actin, and transforming growth factor beta1 in squamous intraepithelial lesions and squamous cell carcinoma of the larynx and hypopharynx. Kojc N, Zidar N, Vodopivec B, Gale N. Hum Pathol; 2005 Jan 01; 36(1):16-21. PubMed ID: 15712177 [Abstract] [Full Text] [Related]
37. Asynchronous modulation of transforming growth factor alpha and epidermal growth factor receptor protein expression in progression of premalignant lesions to head and neck squamous cell carcinoma. Rubin Grandis J, Tweardy DJ, Melhem MF. Clin Cancer Res; 1998 Jan 01; 4(1):13-20. PubMed ID: 9516947 [Abstract] [Full Text] [Related]
38. Stimulation of the murine type II transforming growth factor-beta receptor promoter by the transcription factor Egr-1. Wilder PJ, Bernadt CT, Kim JH, Rizzino A. Mol Reprod Dev; 2002 Nov 01; 63(3):282-90. PubMed ID: 12237943 [Abstract] [Full Text] [Related]
39. A mutation in the transforming growth factor beta type II receptor gene promoter associated with loss of gene expression. Muñoz-Antonia T, Li X, Reiss M, Jackson R, Antonia S. Cancer Res; 1996 Nov 01; 56(21):4831-5. PubMed ID: 8895728 [Abstract] [Full Text] [Related]
40. Epidermal growth factor receptor: a novel biomarker for aggressive head and neck cutaneous squamous cell carcinoma. Ch'ng S, Low I, Ng D, Brasch H, Sullivan M, Davis P, Tan ST. Hum Pathol; 2008 Mar 01; 39(3):344-9. PubMed ID: 18045646 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]